BACKGROUND Different @entity1 with @entity583 ( @entity583 ) have different symptoms. A third of them may have medical emergencies caused by symptoms such as @entity391 and @entity1163 . These concomitant symptoms may influence subsequent therapy and final outcomes. The aim of this study was to determine whether @entity391 is a predictor of clinical outcomes in @entity1 with @entity583 . MATERIAL AND METHODS We classified 152 @entity583 @entity1 from different areas into 2 groups on the basis of @entity391 : group A and group B. Their demographics and conditions of hospitalization were recorded. After follow-up, major adverse @entity299 (MACE) were regarded as study endpoints for the @entity391 in @entity583 @entity1 . RESULTS We found no significant difference in demographic and clinical characteristics of the 2 groups (P>0.05). The hospitalized conditions of group A were more serious than in group B. During a follow-up of 6 months, MACE rate was higher in @entity391 @entity1 (42; 67.7%) compared with group B (25; 27.8%). Multivariate Cox regression analysis revealed that @entity391 was an independent predictor of clinical outcomes. CONCLUSIONS Cardiogenic @entity391 is a useful predictor of major adverse @entity299 in @entity583 @entity1 for the hospitalization and after discharge.

Impact of Cardiogenic Vomiting in @entity1 with XXXX : A Study From China.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity391 :: ('MESH:D014839', 'Disease') :: ['vomiting', 'cardiogenic vomiting', 'effect of cardiogenic vomiting'] @entity1163 :: ('MESH:D013575', 'Disease') :: ['syncope'] @entity299 :: ('MESH:D006331', 'Disease') :: ['cardiac events'] @entity583 :: ('MESH:D009203', 'Disease') :: ['STEMI', 'ST-elevation myocardial infarction']
@entity583 :: (MESH:D009203,Disease) :: ['STEMI']
